Berretta Roberto, Capozzi Vito Andrea, Sozzi Giulio, Volpi Lavinia, Ceni Valentina, Melpignano Mauro, Giordano Giovanna, Marchesi Federico, Monica Michela, Di Serio Maurizio, Riccò Matteo, Ceccaroni Marcello
Department of Obstetrics and Gynecology of Parma, University of Parma, Via Gramsci No. 14, 43125, Parma, Italy.
The Department of Obstetrics and Gynecology of Oglio Po, Cremona, Italy.
Arch Gynecol Obstet. 2018 Apr;297(4):997-1004. doi: 10.1007/s00404-018-4675-y. Epub 2018 Jan 27.
The aim of this retrospective study is to analyze the prognostic role and the practical implication of mesenteric lymph nodes (MLN) involvements in advanced ovarian cancer (AOC).
A total of 429 patients with AOC underwent surgery between December 2007 and May 2017. We included in the study 83 patients who had primary (PDS) or interval debulking surgery (IDS) for AOC with bowel resection. Numbers, characteristics and surgical implication of MLN involvement were considered.
Eighty-three patients were submitted to bowel resection during cytoreduction for AOC. Sixty-seven patients (80.7%) underwent primary debulking surgery (PDS). Sixteen patients (19.3%) experienced interval debulking surgery (IDS). 43 cases (51.8%) showed MLN involvement. A statistic correlation between positive MLN and pelvic lymph nodes (PLN) (p = 0.084), aortic lymph nodes (ALN) (p = 0.008) and bowel infiltration deeper than serosa (p = 0.043) was found. A longer overall survival (OS) and disease-free survival was observed in case of negative MLN in the first 20 months of follow-up. No statistical differences between positive and negative MLN in terms of operative complication, morbidity, Ca-125, type of surgery (radical vs supra-radical), length and site of bowel resection, residual disease and site of recurrence were observed.
An important correlation between positive MLN, ALN and PLN was detected; these results suggest a lymphatic spread of epithelial AOC similar to that of primary bowel cancer. The absence of residual disease after surgery is an independent prognostic factor; to achieve this result should be recommended a radical bowel resection during debulking surgery for AOC with bowel involvement.
本回顾性研究旨在分析肠系膜淋巴结(MLN)受累在晚期卵巢癌(AOC)中的预后作用及实际意义。
2007年12月至2017年5月期间,共有429例AOC患者接受了手术。本研究纳入了83例行AOC肠切除术的初次(PDS)或间隔减瘤手术(IDS)的患者。考虑了MLN受累的数量、特征及手术意义。
83例患者在AOC细胞减灭术中接受了肠切除术。67例患者(80.7%)接受了初次减瘤手术(PDS)。16例患者(19.3%)接受了间隔减瘤手术(IDS)。43例(51.8%)显示有MLN受累。发现MLN阳性与盆腔淋巴结(PLN)(p = 0.084)、主动脉旁淋巴结(ALN)(p = 0.008)及肠浸润深度超过浆膜层(p = 0.043)之间存在统计学相关性。在随访的前20个月中,MLN阴性患者的总生存期(OS)和无病生存期更长。在手术并发症、发病率、Ca-125、手术类型(根治性与超根治性)、肠切除长度和部位、残留病灶及复发部位方面,MLN阳性和阴性患者之间未观察到统计学差异。
检测到MLN阳性与ALN和PLN之间存在重要相关性;这些结果提示上皮性AOC的淋巴转移与原发性肠癌相似。手术后无残留病灶是一个独立的预后因素;对于有肠受累的AOC患者,在减瘤手术期间建议行根治性肠切除术以达到这一结果。